Clinical Study

A Randomized, Double-Blind, Placebo-Controlled Safety Study Of Ds-5565 For Treatment Of Pain Due To Fibromyalgia In Subjects With Chronic Kidney Disease.

Posted Date: Apr 7, 2017

  • Investigator: Lesley Arnold
  • Co-Investigator: Gayathri Pulapaka
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to gather information and test the safety and tolerability of an investigational drug compared to a placebo (inactive substance) that may help treat pain caused by fibromyalgia in people with reduced kidney function.


Adults 18 Years Of Age And Older With Fibromyalgia And Reduced Kidney Function May Be Eligible To Participate


Kidney Disease, Fibromyalgia, Null, Null, Null

For More Information:

Kerri Earles

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.